This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

COVIPEDIA
Loading...

Krammer, Florian


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, Marrama D, de Silva AM, Frazier A, Carlin AF, Greenbaum JA, Peters B, Krammer F, Smith DM, Crotty S, Sette A. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020 May 20. pii: S0092-8674(20)30610-3. doi: 10.1016/j.cell.2020.05.015. [Epub ahead of print] PubMed PMID: 32473127; PubMed Central PMCID: PMC7237901.
38.637
528
1
Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6. Review. PubMed PMID: 32259480; PubMed Central PMCID: PMC7136867.
22.553
305
1
Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA, Jurczyszak D, Polanco J, Bermudez-Gonzalez M, Kleiner G, Aydillo T, Miorin L, Fierer DS, Lugo LA, Kojic EM, Stoever J, Liu STH, Cunningham-Rundles C, Felgner PL, Moran T, García-Sastre A, Caplivski D, Cheng AC, Kedzierska K, Vapalahti O, Hepojoki JM, Simon V, Krammer F. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 May 12. doi: 10.1038/s41591-020-0913-5. [Epub ahead of print] PubMed PMID: 32398876.
36.13
274
1
Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020 Sep 23. doi: 10.1038/s41586-020-2798-3. [Epub ahead of print] Review. PubMed PMID: 32967006.
42.778
94
1
Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Gallego CR, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C; COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank; COVID Human Genetic Effort; NIAID-USUHS; TAGC COVID Immunity Group, Snow AL, Dalgard CL, Milner J, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli M, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton R, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 Sep 24. pii: eabd4570. doi: 10.1126/science.abd4570. [Epub ahead of print] PubMed PMID: 32972995.
41.845
94
1
Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, Yamada S, Fan S, Chiba S, Kuroda M, Guan L, Takada K, Armbrust T, Balogh A, Furusawa Y, Okuda M, Ueki H, Yasuhara A, Sakai-Tagawa Y, Lopes TJS, Kiso M, Yamayoshi S, Kinoshita N, Ohmagari N, Hattori SI, Takeda M, Mitsuya H, Krammer F, Suzuki T, Kawaoka Y. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 Jun 22. pii: 202009799. doi: 10.1073/pnas.2009799117. [Epub ahead of print] PubMed PMID: 32571934.
9.412
73
1
Krammer F, Simon V. Serology assays to manage COVID-19. Science. 2020 May 15. pii: eabc1227. doi: 10.1126/science.abc1227. [Epub ahead of print] PubMed PMID: 32414781.
41.845
67
1
Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, Ciferri B, Alshammary H, Obla A, Fabre S, Kleiner G, Polanco J, Khan Z, Alburquerque B, van de Guchte A, Dutta J, Francoeur N, Melo BS, Oussenko I, Deikus G, Soto J, Sridhar SH, Wang YC, Twyman K, Kasarskis A, Altman DR, Smith M, Sebra R, Aberg J, Krammer F, García-Sastre A, Luksza M, Patel G, Paniz-Mondolfi A, Gitman M, Sordillo EM, Simon V, van Bakel H. Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020 May 29. pii: eabc1917. doi: 10.1126/science.abc1917. [Epub ahead of print] PubMed PMID: 32471856.
41.845
52
1
Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, Sanky C, Dupper A, Zheng A, Nguyen FT, Amanat F, Stadlbauer D, Altman DR, Chen BK, Krammer F, Mendu DR, Firpo-Betancourt A, Levin MA, Bagiella E, Casadevall A, Cordon-Cardo C, Jhang JS, Arinsburg SA, Reich DL, Aberg JA, Bouvier NM. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 Sep 15. doi: 10.1038/s41591-020-1088-9. [Epub ahead of print] PubMed PMID: 32934372.
36.13
49
1
Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, McMahon M, Meade P, Mendu DR, Muellers K, Stadlbauer D, Stone K, Strohmeier S, Simon V, Aberg J, Reich DL, Krammer F, Cordon-Cardo C. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 Oct 28. pii: eabd7728. doi: 10.1126/science.abd7728. [Epub ahead of print] PubMed PMID: 33115920.
41.845
36
1
Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman LR, Greenhalgh T, Gurdasani D, Hamdy A, Hanage WP, Hodcroft EB, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky RP, Yamey G, Ziauddeen H. Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020 Oct 15. pii: S0140-6736(20)32153-X. doi: 10.1016/S0140-6736(20)32153-X. [Epub ahead of print] PubMed PMID: 33069277.
60.392
25
1
Laczkó D, Hogan MJ, Toulmin SA, Hicks P, Lederer K, Gaudette BT, Castaño D, Amanat F, Muramatsu H, Oguin TH 3rd, Ojha A, Zhang L, Mu Z, Parks R, Manzoni TB, Roper B, Strohmeier S, Tombácz I, Arwood L, Nachbagauer R, Karikó K, Greenhouse J, Pessaint L, Porto M, Putman-Taylor T, Strasbaugh A, Campbell TA, Lin PJC, Tam YK, Sempowski GD, Farzan M, Choe H, Saunders KO, Haynes BF, Andersen H, Eisenlohr LC, Weissman D, Krammer F, Bates P, Allman D, Locci M, Pardi N. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 Jul 30. pii: S1074-7613(20)30326-5. doi: 10.1016/j.immuni.2020.07.019. [Epub ahead of print] PubMed PMID: 32783919.
22.553
23
1
Alsoussi WB, Turner JS, Case JB, Zhao H, Schmitz AJ, Zhou JQ, Chen RE, Lei T, Rizk AA, McIntire KM, Winkler ES, Fox JM, Kafai NM, Thackray LB, Hassan AO, Amanat F, Krammer F, Watson CT, Kleinstein SH, Fremont DH, Diamond MS, Ellebedy AH. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol. 2020 Jun 26. pii: ji2000583. doi: 10.4049/jimmunol.2000583. [Epub ahead of print] PubMed PMID: 32591393.
4.886
21
2
Hains DS, Schwaderer AL, Carroll AE, Starr MC, Wilson AC, Amanat F, Krammer F. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. JAMA. 2020 May 14. doi: 10.1001/jama.2020.8438. [Epub ahead of print] PubMed PMID: 32407440; PubMed Central PMCID: PMC7226282.
45.54
16
1
Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, Wilson KM, Onel K, Geanon D, Tuballes K, Patel M, Mouskas K, O'Donnell T, Merritt E, Simons NW, Barcessat V, Del Valle DM, Udondem S, Kang G, Gangadharan S, Ofori-Amanfo G, Laserson U, Rahman A, Kim-Schulze S, Charney AW, Gnjatic S, Gelb BD, Merad M, Bogunovic D. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell. 2020 Sep 14. pii: S0092-8674(20)31231-9. doi: 10.1016/j.cell.2020.09.034. [Epub ahead of print] PubMed PMID: 32991843.
38.637
15
1
Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021 Jan 6. pii: eabf4063. doi: 10.1126/science.abf4063. [Epub ahead of print] PubMed PMID: 33408181.
41.845
13
Wajnberg A, Mansour M, Leven E, Bouvier NM, Patel G, Firpo-Betancourt A, Mendu R, Jhang J, Arinsburg S, Gitman M, Houldsworth J, Sordillo E, Paniz-Mondolfi A, Baine I, Simon V, Aberg J, Krammer F, Reich D, Cordon-Cardo C. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. Lancet Microbe. 2020 Sep 25. doi: 10.1016/S2666-5247(20)30120-8. [Epub ahead of print] PubMed PMID: 33015652; PubMed Central PMCID: PMC7518831.
13
Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, Powell RL. Robust and specific secretory IgA against SARS-CoV-2 detected in human milk. iScience. 2020 Oct 26:101735. doi: 10.1016/j.isci.2020.101735. [Epub ahead of print] PubMed PMID: 33134887; PubMed Central PMCID: PMC7586930.
9
Stadlbauer D, Tan J, Jiang K, Hernandez MM, Fabre S, Amanat F, Teo C, Arunkumar GA, McMahon M, Capuano C, Twyman K, Jhang J, Nowak MD, Simon V, Sordillo EM, van Bakel H, Krammer F. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2020 Nov 3. doi: 10.1038/s41586-020-2912-6. [Epub ahead of print] PubMed PMID: 33142304.
42.778
6
1
Lederer K, Castaño D, Gómez Atria D, Oguin TH 3rd, Wang S, Manzoni TB, Muramatsu H, Hogan MJ, Amanat F, Cherubin P, Lundgreen KA, Tam YK, Fan SHY, Eisenlohr LC, Maillard I, Weissman D, Bates P, Krammer F, Sempowski GD, Pardi N, Locci M. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation. Immunity. 2020 Nov 21. pii: S1074-7613(20)30496-9. doi: 10.1016/j.immuni.2020.11.009. [Epub ahead of print] PubMed PMID: 33296685.
22.553
4
Dingens AS, Crawford KHD, Adler A, Steele SL, Lacombe K, Eguia R, Amanat F, Walls AC, Wolf CR, Murphy M, Pettie D, Carter L, Qin X, King NP, Veesler D, Krammer F, Dickerson JA, Chu HY, Englund JA, Bloom JD. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak. Nat Commun. 2020 Sep 1;11(1):4378. doi: 10.1038/s41467-020-18178-1. PubMed PMID: 32873791.
12.121
4
1
Stadlbauer D, Baine I, Amanat F, Jiang K, Lally K, Krammer F, Jhang JS, Arinsburg SA. Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks. Transfusion. 2020 Aug 14. doi: 10.1111/trf.16047. [Epub ahead of print] PubMed PMID: 32798271.
2.8
3
3
Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, García-Sastre A, Coughlan L, Schotsaert M, Uccellini M. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection. Emerg Microbes Infect. 2020 Oct 17:1-19. doi: 10.1080/22221751.2020.1838955. [Epub ahead of print] PubMed PMID: 33073694.
3
Cordon-Cardo C, Pujadas E, Wajnberg A, Sebra R, Patel G, Firpo-Betancourt A, Fowkes M, Sordillo E, Paniz-Mondolfi A, Gregory J, Krammer F, Simon V, Isola L, Soon-Shiong P, Aberg JA, Fuster V, Reich DL. COVID-19: Staging of a New Disease. Cancer Cell. 2020 Oct 10. pii: S1535-6108(20)30537-7. doi: 10.1016/j.ccell.2020.10.006. [Epub ahead of print] PubMed PMID: 33086031.
26.602
2
1
Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH 3rd, García-Sastre A, Krammer F, Baric RS, Palese P. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. EBioMedicine. 2020 Nov 21;62:103132. doi: 10.1016/j.ebiom.2020.103132. [Epub ahead of print] PubMed PMID: 33232870.
5.736
2
Sun W, McCroskery S, Liu WC, Leist SR, Liu Y, Albrecht RA, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH 3rd, Innis BL, García-Sastre A, Krammer F, Baric RS, Palese P. A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine. Vaccines (Basel). 2020 Dec 17;8(4). pii: E771. doi: 10.3390/vaccines8040771. PubMed PMID: 33348607.
2
Cox RJ, Brokstad KA, Krammer F, Langeland N; Bergen COVID-19 Research Group. Seroconversion in household members of COVID-19 outpatients. Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30466-7. doi: 10.1016/S1473-3099(20)30466-7. [Epub ahead of print] PubMed PMID: 32553187; PubMed Central PMCID: PMC7295487.
24.446
1
1
Weiss S, Klingler J, Hioe C, Amanat F, Baine I, Arinsburg S, Kojic EM, Stoever J, Liu STH, Jurczyszak D, Bermudez-Gonzalez M, Simon V, Krammer F, Zolla-Pazner S. A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2). J Infect Dis. 2020 Aug 29. pii: jiaa531. doi: 10.1093/infdis/jiaa531. [Epub ahead of print] PubMed PMID: 32860510.
5.022
1
1
Lee WT, Girardin RC, Dupuis Ii AP, Kulas KE, Payne AF, Wong SJ, Arinsburg S, Nguyen FT, Mendu DR, Firpo-Betancourt A, Jhang J, Wajnberg A, Krammer F, Cordon-Cardo C, Amler S, Montecalvo M, Hutton B, Taylor J, McDonough KA. Neutralizing Antibody Responses in COVID-19 Convalescent Sera. J Infect Dis. 2020 Oct 26. pii: jiaa673. doi: 10.1093/infdis/jiaa673. [Epub ahead of print] PubMed PMID: 33104179.
5.022
1
1
Nguyen FT, van den Akker T, Lally K, Lam H, Lenskaya V, Liu STH, Bouvier NM, Aberg JA, Rodriguez D, Krammer F, Strauss D, Shaz BH, Rudon L, Galdon P, Jhang JS, Arinsburg SA, Baine I; Mount Sinai Health System Convalescent Plasma Team. Transfusion Reactions Associated with COVID-19 Convalescent Plasma Therapy for SARS-CoV-2. Transfusion. 2020 Oct 30. doi: 10.1111/trf.16177. [Epub ahead of print] PubMed PMID: 33125158.
2.8
1
3
Clifton GT, Pati R, Krammer F, Laing ED, Broder CC, Mendu DR, Simons MP, Chen HW, Sugiharto VA, Kang AD, Stadlbauer D, Pratt KP, Bandera BC, Fritz DK, Millar EV, Burgess TH, Chung KK. SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):308-311. doi: 10.15585/mmwr.mm7009a3. PubMed PMID: 33661864.
13.606
0
Jangra S, De Vrieze J, Choi A, Rathnasinghe R, Laghlali G, Uvyn A, Van Herck S, Nuhn L, Deswarte K, Zhong Z, Sanders N, Lienenklaus S, David S, Strohmeier S, Amanat F, Krammer F, Hammad H, Lambrecht BN, Coughlan L, García-Sastre A, de Geest B, Schotsaert M. Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine. Angew Chem Int Ed Engl. 2021 Jan 19. doi: 10.1002/anie.202015362. [Epub ahead of print] PubMed PMID: 33464672.
12.959
0
Rusanen J, Kareinen L, Levanov L, Mero S, Pakkanen SH, Kantele A, Amanat F, Krammer F, Hedman K, Vapalahti O, Hepojoki J. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2. Viruses. 2021 Jan 20;13(2). pii: E143. doi: 10.3390/v13020143. PubMed PMID: 33498157.
3.816
0
Nailescu C, Khalid M, Wilson AC, Amanat F, Arregui S, Canas J, Hooks J, Krammer F, Schwaderer AL, Hains DS. Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients. Front Pediatr. 2020 Oct 30;8:601327. doi: 10.3389/fped.2020.601327. eCollection 2020. PubMed PMID: 33194930; PubMed Central PMCID: PMC7661782.
2.634
0
Gupta A, Malhotra Y, Patil U, Muradas AR, Lee WT, Krammer F, Amanat F, Clare CA, Vinod S, Ghaly E. In Utero Vertical Transmission of Coronavirus Disease 2019 in a Severely Ill 29-week Preterm Infant. AJP Rep. 2020 Jul;10(3):e270-e274. doi: 10.1055/s-0040-1715177. Epub 2020 Sep 16. PubMed PMID: 33094016; PubMed Central PMCID: PMC7571549.
0
Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF, Bermúdez-González MC, Bielak DA, Carreño JM, Chernet RL, Eaker LQ, Ferreri ED, Floda DL, Gleason CR, Hamburger JZ, Jiang K, Kleiner G, Jurczyszak D, Matthews JC, Mendez WA, Nabeel I, Mulder LCF, Raskin AJ, Russo KT, Salimbangon AT, Saksena M, Shin AS, Singh G, Sominsky LA, Stadlbauer D, Wajnberg A, Simon V. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667. [Epub ahead of print] PubMed PMID: 33691060.
74.699
Stadlbauer D, Amanat F, Chromikova V, Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C, Kirkpatrick E, Meade P, Brito RN, Teo C, McMahon M, Simon V, Krammer F. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 2020 Jun;57(1):e100. doi: 10.1002/cpmc.100. PubMed PMID: 32302069; PubMed Central PMCID: PMC7235504.
70.67
Krammer F. Correlates of protection from SARS-CoV-2 infection. Lancet. 2021 Apr 9. pii: S0140-6736(21)00782-0. doi: 10.1016/S0140-6736(21)00782-0. [Epub ahead of print] PubMed PMID: 33844964.
60.39
Alter G, Yu J, Liu J, Chandrashekar A, Borducchi EN, Tostanoski LH, McMahan K, Jacob-Dolan C, Martinez DR, Chang A, Anioke T, Lifton M, Nkolola J, Stephenson KE, Atyeo C, Shin S, Fields P, Kaplan I, Robins H, Amanat F, Krammer F, Baric RS, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Struyf F, Douoguih M, van Hoof J, Schuitemaker H, Barouch DH. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 Jun 9. doi: 10.1038/s41586-021-03681-2. [Epub ahead of print] PubMed PMID: 34107529.
42.779
Turner JS, O'Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, Lei T, Thapa M, Chen RE, Case JB, Amanat F, Rauseo AM, Haile A, Xie X, Klebert MK, Suessen T, Middleton WD, Shi PY, Krammer F, Teefey SA, Diamond MS, Presti RM, Ellebedy AH. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 Jun 28. doi: 10.1038/s41586-021-03738-2. [Epub ahead of print] PubMed PMID: 34182569.
42.779
Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol. 2021 Mar 15. doi: 10.1038/s41577-021-00522-1. [Epub ahead of print] Review. PubMed PMID: 33723416.
40.358
Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H; Personalized Virology Initiative, Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021 Jun 8. pii: S0092-8674(21)00706-6. doi: 10.1016/j.cell.2021.06.005. [Epub ahead of print] PubMed PMID: 34192529.
38.637
Krammer F. A correlate of protection for SARS-CoV-2 vaccines is urgently needed. Nat Med. 2021 Jul 8. doi: 10.1038/s41591-021-01432-4. [Epub ahead of print] PubMed PMID: 34239135.
36.13
Van Oekelen O, Gleason CR, Agte S, Srivastava K, Beach KF, Aleman A, Kappes K; PVI/Seronet team, Mouhieddine TH, Wang B, Chari A, Cordon-Cardo C, Krammer F, Jagannath S, Simon V, Wajnberg A, Parekh S. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell. 2021 Jun 29. pii: S1535-6108(21)00336-6. doi: 10.1016/j.ccell.2021.06.014. [Epub ahead of print] PubMed PMID: 34242572.
26.602
Letizia AG, Ge Y, Vangeti S, Goforth C, Weir DL, Kuzmina NA, Balinsky CA, Chen HW, Ewing D, Soares-Schanoski A, George MC, Graham WD, Jones F, Bharaj P, Lizewski RA, Lizewski SE, Marayag J, Marjanovic N, Miller CM, Mofsowitz S, Nair VD, Nunez E, Parent DM, Porter CK, Santa Ana E, Schilling M, Stadlbauer D, Sugiharto VA, Termini M, Sun P, Tracy RP, Krammer F, Bukreyev A, Ramos I, Sealfon SC. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021 Apr 15. pii: S2213-2600(21)00158-2. doi: 10.1016/S2213-2600(21)00158-2. [Epub ahead of print] PubMed PMID: 33865504.
25.094
Schmitz AJ, Turner JS, Liu Z, Zhou JQ, Aziati ID, Chen RE, Joshi A, Bricker TL, Darling TL, Adelsberg DC, Altomare CG, Alsoussi WB, Case JB, VanBlargan LA, Lei T, Thapa M, Amanat F, Jeevan T, Fabrizio T, O'Halloran JA, Shi PY, Presti RM, Webby RJ, Krammer F, Whelan SPJ, Bajic G, Diamond MS, Boon ACM, Ellebedy AH. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants. Immunity. 2021 Aug 17. pii: S1074-7613(21)00345-9. doi: 10.1016/j.immuni.2021.08.013. [Epub ahead of print] PubMed PMID: 34464596.
22.553
Nguyen THO, Rowntree LC, Petersen J, Chua BY, Hensen L, Kedzierski L, van de Sandt CE, Chaurasia P, Tan HX, Habel JR, Zhang W, Allen LF, Earnest L, Mak KY, Juno JA, Wragg K, Mordant FL, Amanat F, Krammer F, Mifsud NA, Doolan DL, Flanagan KL, Sonda S, Kaur J, Wakim LM, Westall GP, James F, Mouhtouris E, Gordon CL, Holmes NE, Smibert OC, Trubiano JA, Cheng AC, Harcourt P, Clifton P, Crawford JC, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Torresi J, Kedzierska K. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 Apr 15. pii: S1074-7613(21)00171-0. doi: 10.1016/j.immuni.2021.04.009. [Epub ahead of print] PubMed PMID: 33951417.
22.553
Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, Nelson CA, Dai YN, Hall PD, Jedrzejczak RP, Joachimiak A, Krammer F, Diamond MS, Fremont DH, Kawaoka Y, Wilson PC. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 May 6. pii: S1074-7613(21)00198-9. doi: 10.1016/j.immuni.2021.05.001. [Epub ahead of print] PubMed PMID: 34022127.
22.553
Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC; International Organization for the Study of Inflammatory Bowel Disease (IOIBD); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021 Jan 20. pii: gutjnl-2020-324000. doi: 10.1136/gutjnl-2020-324000. [Epub ahead of print] PubMed PMID: 33472895.
19.819
van Doremalen N, Purushotham JN, Schulz JE, Holbrook MG, Bushmaker T, Carmody A, Port JR, Yinda CK, Okumura A, Saturday G, Amanat F, Krammer F, Hanley PW, Smith BJ, Lovaglio J, Anzick SL, Barbian K, Martens C, Gilbert SC, Lambe T, Munster VJ. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci Transl Med. 2021 Jul 27. pii: eabh0755. doi: 10.1126/scitranslmed.abh0755. [Epub ahead of print] PubMed PMID: 34315826.
16.304
Amanat F, White KM, Miorin L, Strohmeier S, McMahon M, Meade P, Liu WC, Albrecht RA, Simon V, Martinez-Sobrido L, Moran T, García-Sastre A, Krammer F. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol. 2020 Sep;58(1):e108. doi: 10.1002/cpmc.108. PubMed PMID: 32585083.
15.753
Jangra S, De Vrieze J, Choi A, Rathnasinghe R, Laghlali G, Uvyn A, Van Herck S, Nuhn L, Deswarte K, Zhong Z, Sanders NN, Lienenklaus S, David SA, Strohmeier S, Amanat F, Krammer F, Hammad H, Lambrecht BN, Coughlan L, García-Sastre A, De Geest BG, Schotsaert M. Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine. Angew Chem Int Ed Engl. 2021 Jul 26;60(31):16741-16742. doi: 10.1002/anie.202105635. PubMed PMID: 34278670.
12.959
Selva KJ, van de Sandt CE, Lemke MM, Lee CY, Shoffner SK, Chua BY, Davis SK, Nguyen THO, Rowntree LC, Hensen L, Koutsakos M, Wong CY, Mordant F, Jackson DC, Flanagan KL, Crowe J, Tosif S, Neeland MR, Sutton P, Licciardi PV, Crawford NW, Cheng AC, Doolan DL, Amanat F, Krammer F, Chappell K, Modhiran N, Watterson D, Young P, Lee WS, Wines BD, Mark Hogarth P, Esterbauer R, Kelly HG, Tan HX, Juno JA, Wheatley AK, Kent SJ, Arnold KB, Kedzierska K, Chung AW. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 Apr 1;12(1):2037. doi: 10.1038/s41467-021-22236-7. PubMed PMID: 33795692.
12.121
Hernandez MM, Gonzalez-Reiche AS, Alshammary H, Fabre S, Khan Z, van De Guchte A, Obla A, Ellis E, Sullivan MJ, Tan J, Alburquerque B, Soto J, Wang CY, Sridhar SH, Wang YC, Smith M, Sebra R, Paniz-Mondolfi AE, Gitman MR, Nowak MD, Cordon-Cardo C, Luksza M, Krammer F, van Bakel H, Simon V, Sordillo EM. Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave. Nat Commun. 2021 Jun 8;12(1):3463. doi: 10.1038/s41467-021-23688-7. PubMed PMID: 34103497.
12.121
Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda-Alonso G, Escalera A, Amanat F, Jiang K, Krammer F, Carratala J, García-Sastre A. Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 Jun 18;12(1):3781. doi: 10.1038/s41467-021-23977-1. PubMed PMID: 34145263.
12.121
Canas JJ, Starr MC, Hooks J, Arregui S, Wilson AC, Carroll AE, Saxena V, Amanat F, Krammer F, Fill J, Schade A, Chambers A, Schneider J, Schwaderer AL, Hains DS. Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit. Kidney Int. 2021 Feb;99(2):484-486. doi: 10.1016/j.kint.2020.11.014. PubMed PMID: 33509357.
8.945
Oguntuyo KY, Stevens CS, Hung CT, Ikegame S, Acklin JA, Kowdle SS, Carmichael JC, Chiu HP, Azarm KD, Haas GD, Amanat F, Klingler J, Baine I, Arinsburg S, Bandres JC, Siddiquey MNA, Schilke RM, Woolard MD, Zhang H; COVIDAR Argentina Consortium, Duty AJ, Kraus TA, Moran TM, Tortorella D, Lim JK, Gamarnik AV, Hioe CE, Zolla-Pazner S, Ivanov SS, Kamil JP, Krammer F, Lee B. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio. 2021 Feb 16;12(1). pii: e02492-20. doi: 10.1128/mBio.02492-20. PubMed PMID: 33593976.
6.784
Guthmiller JJ, Stovicek O, Wang J, Changrob S, Li L, Halfmann P, Zheng NY, Utset H, Stamper CT, Dugan HL, Miller WD, Huang M, Dai YN, Nelson CA, Hall PD, Jansen M, Shanmugarajah K, Donington JS, Krammer F, Fremont DH, Joachimiak A, Kawaoka Y, Tesic V, Madariaga ML, Wilson PC. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. mBio. 2021 Jan 19;12(1). pii: e02940-20. doi: 10.1128/mBio.02940-20. PubMed PMID: 33468695.
6.784
Amanat F, Strohmeier S, Rathnasinghe R, Schotsaert M, Coughlan L, García-Sastre A, Krammer F. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio. 2021 Mar 2;12(2). pii: e02648-20. doi: 10.1128/mBio.02648-20. PubMed PMID: 33653892.
6.784
Amanat F, Strohmeier S, Lee WH, Bangaru S, Ward AB, Coughlan L, Krammer F. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner. mBio. 2021 Jul 27:e0100221. doi: 10.1128/mBio.01002-21. [Epub ahead of print] PubMed PMID: 34311574.
6.784
Lara-Puente JH, Carreño JM, Sun W, Suárez-Martínez A, Ramírez-Martínez L, Quezada-Monroy F, Paz-De la Rosa G, Vigueras-Moreno R, Singh G, Rojas-Martínez O, Chagoya-Cortés HE, Sarfati-Mizrahi D, Soto-Priante E, López-Macías C, Krammer F, Castro-Peralta F, Palese P, García-Sastre A, Lozano-Dubernard B. Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs. mBio. 2021 Sep 21:e0190821. doi: 10.1128/mBio.01908-21. [Epub ahead of print] PubMed PMID: 34544278.
6.784
Jangra S, De Vrieze J, Choi A, Rathnasinghe R, Laghlali G, Uvyn A, Van Herck S, Nuhn L, Deswarte K, Zhong Z, Sanders N, Lienenklaus S, David S, Strohmeier S, Amanat F, Krammer F, Hammad H, Lambrecht BN, Coughlan L, Garcia-Sastre A, De Geest BG, Schotsaert M. Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine. bioRxiv. 2020 Oct 23. pii: 2020.10.23.344085. doi: 10.1101/2020.10.23.344085. PubMed PMID: 33106810; PubMed Central PMCID: PMC7587831.
6.763
Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S. Immunological memory to SARS-CoV-2 assessed for up to eight months after infection. bioRxiv. 2020 Dec 18. pii: 2020.11.15.383323. doi: 10.1101/2020.11.15.383323. PubMed PMID: 33442687; PubMed Central PMCID: PMC7805444.
6.763
van Doremalen N, Purushotham J, Schulz J, Holbrook M, Bushmaker T, Carmody A, Port J, Yinda KC, Okumura A, Saturday G, Amanat F, Krammer F, Hanley P, Smith B, Lovaglio J, Anzick S, Barbian K, Martens C, Gilbert SC, Lambe T, Munster V. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques. bioRxiv. 2021 Jan 11. pii: 2021.01.09.426058. doi: 10.1101/2021.01.09.426058. PubMed PMID: 33447831; PubMed Central PMCID: PMC7808328.
6.763
da Silva Antunes R, Pallikkuth S, Williams E, Yu ED, Mateus J, Quiambao L, Wang E, Rawlings SA, Stadlbauer D, Jiang K, Amanat F, Arnold D, Andrews D, Fuego I, Dan JM, Grifoni A, Weiskopf D, Krammer F, Crotty S, Hoffer ME, Pahwa SG, Sette A. Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers. medRxiv. 2021 Jan 15. pii: 2021.01.12.21249683. doi: 10.1101/2021.01.12.21249683. PubMed PMID: 33469594; PubMed Central PMCID: PMC7814840.
6.763
Rathnasinghe R, Jangra S, Cupic A, Martínez-Romero C, Mulder LCF, Kehrer T, Yildiz S, Choi A, Mena I, De Vrieze J, Aslam S, Stadlbauer D, Meekins DA, McDowell CD, Balaraman V, Richt JA, De Geest BG, Miorin L, Krammer F, Simon V, García-Sastre A, Schotsaert M. The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera. medRxiv. 2021 Jan 20. pii: 2021.01.19.21249592. doi: 10.1101/2021.01.19.21249592. PubMed PMID: 33501468; PubMed Central PMCID: PMC7836140.
6.763
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo KY, Stevens C, Ikegame S, Hung CT, Enyindah-Asonye G, Amanat F, Baine I, Arinsburg S, Bandres JC, Kojic EM, Stoever J, Jurczyszak D, Bermudez-Gonzalez M, Simon V, Nádas A, Liu S, Lee B, Krammer F, Zolla-Pazner S, Hioe CE. Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv. 2020 Nov 2. pii: 2020.08.18.20177303. doi: 10.1101/2020.08.18.20177303. PubMed PMID: 33173891; PubMed Central PMCID: PMC7654883.
6.763
Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche A, Siu S, Tankelevich M, Grinspan L, Dixon RE, Jha D, Martinez-Delgado G, Amanat F, Hoagland DA, tenOever B, Dubinsky MC, Merad M, van Bakel H, Krammer F, Bongers G, Mehandru S, Faith JJ. SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19. medRxiv. 2020 Sep 5. pii: 2020.09.03.20183947. doi: 10.1101/2020.09.03.20183947. PubMed PMID: 32909002; PubMed Central PMCID: PMC7480054.
6.763
Guthmiller JJ, Stovicek O, Wang J, Changrob S, Li L, Halfmann P, Zheng NY, Utset H, Stamper CT, Dugan HL, Miller WD, Huang M, Dai YN, Nelson CA, Hall PD, Jansen M, Shanmugarajah K, Donington JS, Krammer F, Fremont D, Joachimiak A, Kawaoka Y, Tesic V, Madariaga ML, Wilson PC. SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike. bioRxiv. 2020 Sep 13. pii: 2020.09.12.294066. doi: 10.1101/2020.09.12.294066. PubMed PMID: 32935099; PubMed Central PMCID: PMC7491512.
6.763
Amanat F, Strohmeier S, Rathnasinghe R, Schotsaert M, Coughlan L, García-Sastre A, Krammer F. Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model. bioRxiv. 2020 Sep 17. pii: 2020.09.16.300970. doi: 10.1101/2020.09.16.300970. PubMed PMID: 32995785; PubMed Central PMCID: PMC7523111.
6.763
Wilson P, Stamper C, Dugan H, Li L, Asby N, Halfmann P, Guthmiller J, Zheng NY, Huang M, Stovicek O, Wang J, Madariaga ML, Shanmugarajah K, Jansen M, Amanat F, Stewart I, Changrob S, Utset H, Huang J, Nelson C, Dai YN, Hall P, Jedrzejczak R, Joachimiak A, Krammer F, Fremont D, Kawaoka Y. Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2. Res Sq. 2020 Sep 25. pii: rs.3.rs-80476. doi: 10.21203/rs.3.rs-80476/v1. PubMed PMID: 32995763; PubMed Central PMCID: PMC7523131.
6.763
Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon K, Garcia-Sastre A, Krammer F, Baric RS, Palese P. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate. bioRxiv. 2020 Jul 26. pii: 2020.07.26.221861. doi: 10.1101/2020.07.26.221861. PubMed PMID: 32743571; PubMed Central PMCID: PMC7386488.
6.763
Sun W, McCroskery S, Liu WC, Leist SR, Liu Y, Albrecht RA, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon KH, Innis BL, Garcia-Sastre A, Krammer F, Baric RS, Palese P. A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. bioRxiv. 2020 Jul 31. pii: 2020.07.30.229120. doi: 10.1101/2020.07.30.229120. PubMed PMID: 32766572; PubMed Central PMCID: PMC7402029.
6.763
Oguntuyo KY, Stevens CS, Hung CT, Ikegame S, Acklin JA, Kowdle SS, Carmichael JC, Chiu HP, Azarm KD, Haas GD, Amanat F, Klingler J, Baine I, Arinsburg S, Bandres JC, Siddiquey MN, Schilke RM, Woolard MD, Zhang H, Duty AJ, Kraus TA, Moran TM, Tortorella D, Lim JK, Gamarnik AV, Hioe CE, Zolla-Pazner S, Ivanov SS, Kamil JP, Krammer F, Lee B. Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera. medRxiv. 2020 Aug 15. pii: 2020.08.13.20157222. doi: 10.1101/2020.08.13.20157222. PubMed PMID: 32817961; PubMed Central PMCID: PMC7430605.
6.763
Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J; COVID Human Genetic Effort; French COVID Cohort Study Group; CoV-Contact Cohort, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP. Inhibition of HECT E3 ligases as potential therapy for COVID-19. Cell Death Dis. 2021 Mar 24;12(4):310. doi: 10.1038/s41419-021-03513-1. PubMed PMID: 33762578.
6.304
Frieman M, Harris AD, Herati RS, Krammer F, Mantovani A, Rescigno M, Sajadi MM, Simon V. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors. EBioMedicine. 2021 May 25;68:103401. doi: 10.1016/j.ebiom.2021.103401. [Epub ahead of print] PubMed PMID: 34051441.
5.736
da Silva Antunes R, Pallikkuth S, Williams E, Esther DY, Mateus J, Quiambao L, Wang E, Rawlings SA, Stadlbauer D, Jiang K, Amanat F, Arnold D, Andrews D, Fuego I, Dan JM, Grifoni A, Weiskopf D, Krammer F, Crotty S, Hoffer ME, Pahwa SG, Sette A. Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers. J Infect Dis. 2021 Apr 2. pii: jiab176. doi: 10.1093/infdis/jiab176. [Epub ahead of print] PubMed PMID: 33822097.
5.022
Trieu MC, Bansal A, Madsen A, Zhou F, Sævik M, Vahokoski J, Brokstad KA, Krammer F, Tøndel C, Mohn KGI, Blomberg B, Langeland N, Cox RJ. SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. J Infect Dis. 2020 Nov 28. pii: jiaa737. doi: 10.1093/infdis/jiaa737. [Epub ahead of print] PubMed PMID: 33247924.
5.022
Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, Tankelevich M, Grinspan LT, Dixon RE, Jha D, van de Guchte A, Khan Z, Martinez-Delgado G, Amanat F, Hoagland DA, tenOever BR, Dubinsky MC, Merad M, van Bakel H, Krammer F, Bongers G, Mehandru S, Faith JJ. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021 Jun 25;11(1):13308. doi: 10.1038/s41598-021-92740-9. PubMed PMID: 34172783.
3.998
Phelan T, Dunne J, Conlon N, Cheallaigh CN, Abbott WM, Faba-Rodriguez R, Amanat F, Krammer F, Little MA, Hughes G, Bergin C, Kerr C, Sundaresan S, Long A, McCormack W, Brady G. Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity. Viruses. 2021 Jul 15;13(7). pii: 1371. doi: 10.3390/v13071371. PubMed PMID: 34372581.
3.816
Weiss S, Klingler J, Hioe C, Amanat F, Baine I, Kojic EM, Stoever J, Liu S, Jurczyszak D, Bermudez-Gonzalez M, Simon V, Krammer F, Zolla-Pazner S. A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2. medRxiv. 2020 Apr 17. pii: 2020.04.14.20059501. doi: 10.1101/2020.04.14.20059501. PubMed PMID: 32511609; PubMed Central PMCID: PMC7276036.
3.621
Dingens AS, Crawford KH, Adler A, Steele SL, Lacombe K, Eguia R, Amanat F, Walls AC, Wolf CR, Murphy M, Pettie D, Carter L, Qin X, King NP, Veesler D, Krammer F, Chu HY, Englund JA, Bloom JD. Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak. medRxiv. 2020 May 28. pii: 2020.05.26.20114124. doi: 10.1101/2020.05.26.20114124. PubMed PMID: 32511483; PubMed Central PMCID: PMC7273251.
3.621
Chakraborty S, Edwards K, Buzzanco AS, Memoli MJ, Sherwood R, Mallajosyula V, Xie MM, Gonzalez J, Buffone C, Kathale N, Providenza S, Jagannathan P, Andrews JR, Blish CA, Krammer F, Dugan H, Wilson PC, Pham TD, Boyd SD, Zhang S, Taubenberger JK, Morales T, Schapiro JM, Parsonnet J, Wang TT. Symptomatic SARS-CoV-2 infections display specific IgG Fc structures. medRxiv. 2020 May 18. pii: 2020.05.15.20103341. doi: 10.1101/2020.05.15.20103341. PubMed PMID: 32511463; PubMed Central PMCID: PMC7252581.
3.621
Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Asthagiri Arunkumar G, Jurczyszak D, Polanco J, Bermudez-Gonzalez M, Kleiner G, Aydillo T, Miorin L, Fierer D, Amarilis Lugo L, Milunka Kojic E, Stoever J, Liu STH, Cunningham-Rundles C, Felgner PL, Moran T, Garcia-Sastre A, Caplivski D, Cheng A, Kedzierska K, Vapalahti O, Hepojoki JM, Simon V, Krammer F. A serological assay to detect SARS-CoV-2 seroconversion in humans. medRxiv. 2020 Apr 16. pii: 2020.03.17.20037713. doi: 10.1101/2020.03.17.20037713. Update in: Nat Med. 2020 May 12;:. PubMed PMID: 32511441; PubMed Central PMCID: PMC7239062.
3.621
Gruber C, Patel R, Trachman R, Lepow L, Amanat F, Krammer F, Wilson KM, Onel K, Geanon D, Tuballes K, Patel M, Mouskas K, Simons N, Barcessat V, Del Valle D, Udondem S, Kang G, Gangadharan S, Ofori-Amanfo G, Rahman A, Kim-Schulze S, Charney A, Gnjatic S, Gelb B, Merad M, Bogunovic D. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). medRxiv. 2020 Jul 6. pii: 2020.07.04.20142752. doi: 10.1101/2020.07.04.20142752. PubMed PMID: 32676612; PubMed Central PMCID: PMC7359537.
3.621
Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, García-Sastre A, Coughlan L, Schotsaert M, Uccellini M. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection. bioRxiv. 2020 Jul 6. pii: 2020.07.06.190066. doi: 10.1101/2020.07.06.190066. PubMed PMID: 32676603; PubMed Central PMCID: PMC7359525.
3.621
Werzberger A, Carreño JM, Team SS, Polinger A, Krammer F, Zachariah P. Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control. Am J Infect Control. 2021 Aug 20. pii: S0196-6553(21)00549-6. doi: 10.1016/j.ajic.2021.08.015. [Epub ahead of print] PubMed PMID: 34425179.
2.294
Muena NA, García-Salum T, Pardo-Roa C, Serrano EF, Levican J, Avendaño MJ, Almonacid LI, Valenzuela G, Poblete E, Strohmeier S, Salinas E, Haslwanter D, Dieterle ME, Jangra RK, Chandran K, González C, Riquelme A, Krammer F, Tischler ND, Medina RA. Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines. medRxiv. 2021 May 18. pii: 2021.05.17.21257197. doi: 10.1101/2021.05.17.21257197. PubMed PMID: 34031662; PubMed Central PMCID: PMC8142662.
1.18
Wilson P, Changrob S, Fu Y, Guthmiller J, Halfmann P, Li L, Stamper C, Dugan H, Accola M, Rehrauer W, Zheng NY, Huang M, Wang J, Erickson S, Utset H, Graves H, Amanat F, Sather DN, Krammer F, Kawaoka Y. Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike. Res Sq. 2021 Jul 19. pii: rs.3.rs-678247. doi: 10.21203/rs.3.rs-678247/v1. PubMed PMID: 34312615; PubMed Central PMCID: PMC8312900.
1.18
Pitisuttithum P, Luvira V, Lawpoolsri S, Muangnoicharoen S, Kamolratanakul S, Sivakorn C, Narakorn P, Surichan S, Prangpratanporn S, Puksuriwong S, Lamola S, Mercer LD, Raghunandan R, Sun W, Liu Y, Carreño JM, Scharf R, Phumratanaprapin W, Amanat F, Gagnon L, Hsieh CL, Kaweepornpoj R, Khan S, Lal M, McCroskery S, McLellan J, Mena I, Meseck M, Phonrat B, Sabmee Y, Singchareon R, Slamanig S, Suthepakul N, Tcheou J, Thantamnu N, Theerasurakarn S, Tran S, Vilasmongkolchai T, White JA, Garcia-Sastre A, Palese P, Krammer F, Poopipatpol K, Wirachwong P, Hjorth R, Innis BL. Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial. medRxiv. 2021 Sep 22. pii: 2021.09.17.21263758. doi: 10.1101/2021.09.17.21263758. PubMed PMID: 34580673; PubMed Central PMCID: PMC8475960.
1.18
Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner S, Hensen L, Boyd D, James F, Mouhtouris E, Kwong J, Chua K, Drewett G, Copaescu A, Dobson J, Rowntree L, Habel J, Allen L, Koay HF, Neil J, Gartner M, Lee C, Andersson P, Seemann T, Sherry N, Amanat F, Krammer F, Londrigan S, Wakim L, King N, Godfrey D, Mackay L, Thomas P, Nicholson S, Arnold K, Chung A, Holmes N, Smibert O, Trubiano J, Gordon C, Nguyen T, Kedzierska K. Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. Res Sq. 2021 Aug 26. pii: rs.3.rs-802084. doi: 10.21203/rs.3.rs-802084/v1. PubMed PMID: 34462740; PubMed Central PMCID: PMC8404907.
1.18
Ying B, Whitener B, VanBlargan LA, Hassan AO, Shrihari S, Liang CY, Karl CE, Mackin S, Chen RE, Kafai NM, Wilks SH, Smith DJ, Carreño JM, Singh G, Krammer F, Carfi A, Elbashir S, Edwards DK, Thackray LB, Diamond MS. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. bioRxiv. 2021 Aug 26. pii: 2021.08.25.457693. doi: 10.1101/2021.08.25.457693. PubMed PMID: 34462745; PubMed Central PMCID: PMC8404887.
1.18
Kaplonek P, Cizmeci D, Fischinger S, Collier AR, Suscovich T, Linde C, Broge T, Mann C, Amanat F, Dayal D, Rhee J, de St Aubin M, Nilles EJ, Musk ER, Menon AS, Saphire EO, Krammer F, Lauffenburger DA, Barouch DH, Alter G. Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles. bioRxiv. 2021 Aug 31. pii: 2021.08.31.458247. doi: 10.1101/2021.08.31.458247. PubMed PMID: 34494026; PubMed Central PMCID: PMC8423223.
1.18
Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreno JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H; Personalized Virology Initiative, Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F. The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD. medRxiv. 2021 Mar 9. pii: 2021.03.07.21253098. doi: 10.1101/2021.03.07.21253098. PubMed PMID: 33758878; PubMed Central PMCID: PMC7987037.
1.18
Schmitz AJ, Turner JS, Liu Z, Aziati ID, Chen RE, Joshi A, Bricker TL, Darling TL, Adelsberg DC, Alsoussi WB, Case JB, Lei T, Thapa M, Amanat F, O'Halloran JA, Shi PY, Presti RM, Krammer F, Bajic G, Whelan SPJ, Diamond MS, Boon ACM, Ellebedy AH. A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants. bioRxiv. 2021 Mar 24. pii: 2021.03.24.436864. doi: 10.1101/2021.03.24.436864. PubMed PMID: 33791696; PubMed Central PMCID: PMC8010723.
1.18
Alter G, Gorman M, Patel N, Guebre-Xabier M, Zhu A, Atyeo C, Pullen K, Loos C, Goez-Gazi Y, Carrion R, Tian JH, Yuan D, Bowman K, Zhou B, Maciejewski S, McGrath M, Logue J, Frieman M, Montefiori D, Schendel S, Saphire EO, Lauffenburger D, Greene A, Portnoff A, Massare M, Ellingsworth L, Glenn G, Smith G, Mann C, Amanat F, Krammer F. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. Res Sq. 2021 Feb 15. pii: rs.3.rs-200342. doi: 10.21203/rs.3.rs-200342/v1. PubMed PMID: 33619473; PubMed Central PMCID: PMC7899467.
1.18
Jangra S, Ye C, Rathnasinghe R, Stadlbauer D, Krammer F, Simon V, Martinez-Sobrido L, Garcia-Sastre A, Schotsaert M. The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. medRxiv. 2021 Jan 29. pii: 2021.01.26.21250543. doi: 10.1101/2021.01.26.21250543. PubMed PMID: 33532796; PubMed Central PMCID: PMC7852247.
1.18
Gorman MJ, Patel N, Guebre-Xabier M, Zhu A, Atyeo C, Pullen KM, Loos C, Goez-Gazi Y, Carrion R, Tian JH, Yaun D, Bowman K, Zhou B, Maciejewski S, McGrath ME, Logue J, Frieman MB, Montefiori D, Mann C, Schendel S, Amanat F, Krammer F, Saphire EO, Lauffenburger D, Greene AM, Portnoff AD, Massare MJ, Ellingsworth L, Glenn G, Smith G, Alter G. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. bioRxiv. 2021 Feb 5. pii: 2021.02.05.429759. doi: 10.1101/2021.02.05.429759. PubMed PMID: 33564763; PubMed Central PMCID: PMC7872351.
1.18
Rowntree LC, Chua BY, Nicholson S, Koutsakos M, Hensen L, Douros C, Selva K, Mordant FL, Wong CY, Habel JR, Zhang W, Jia X, Allen L, Doolan DL, Jackson DC, Wheatley AK, Kent SJ, Amanat F, Krammer F, Subbarao K, Cheng AC, Chung AW, Catton M, Nguyen TH, van de Sandt CE, Kedzierska K. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021 Feb 28;10(3):e1258. doi: 10.1002/cti2.1258. eCollection 2021. PubMed PMID: 33680466; PubMed Central PMCID: PMC7916820.
Krammer F. Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time? Med (N Y). 2020 Dec 18;1(1):28-32. doi: 10.1016/j.medj.2020.11.004. Epub 2020 Dec 5. PubMed PMID: 33521752; PubMed Central PMCID: PMC7836605.
Koutsakos M, Rowntree LC, Hensen L, Chua BY, van de Sandt CE, Habel JR, Zhang W, Jia X, Kedzierski L, Ashhurst TM, Putri GH, Marsh-Wakefield F, Read MN, Edwards DN, Clemens EB, Wong CY, Mordant FL, Juno JA, Amanat F, Audsley J, Holmes NE, Gordon CL, Smibert OC, Trubiano JA, Hughes CM, Catton M, Denholm JT, Tong SY, Doolan DL, Kotsimbos TC, Jackson DC, Krammer F, Godfrey DI, Chung AW, King NJ, Lewin SR, Wheatley AK, Kent SJ, Subbarao K, McMahon J, Thevarajan I, Nguyen TH, Cheng AC, Kedzierska K. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 Feb 5:100208. doi: 10.1016/j.xcrm.2021.100208. [Epub ahead of print] PubMed PMID: 33564749; PubMed Central PMCID: PMC7862905.
Carreño JM, Mendu DR, Simon V, Shariff MA, Singh G, Menon V, Krammer F. Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms. iScience. 2021 Jul 31:102937. doi: 10.1016/j.isci.2021.102937. [Epub ahead of print] PubMed PMID: 34368647; PubMed Central PMCID: PMC8324485.
Gorman MJ, Patel N, Guebre-Xabier M, Zhu AL, Atyeo C, Pullen KM, Loos C, Goez-Gazi Y, Carrion R Jr, Tian JH, Yuan D, Bowman KA, Zhou B, Maciejewski S, McGrath ME, Logue J, Frieman MB, Montefiori D, Mann C, Schendel S, Amanat F, Krammer F, Saphire EO, Lauffenburger D, Greene AM, Portnoff AD, Massare MJ, Ellingsworth L, Glenn G, Smith G, Alter G. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination. Cell Rep Med. 2021 Aug 31:100405. doi: 10.1016/j.xcrm.2021.100405. [Epub ahead of print] PubMed PMID: 34485950; PubMed Central PMCID: PMC8405506.
Jangra S, Ye C, Rathnasinghe R, Stadlbauer D; Personalized Virology Initiative study group, Krammer F, Simon V, Martinez-Sobrido L, García-Sastre A, Schotsaert M. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021 Apr 7. doi: 10.1016/S2666-5247(21)00068-9. [Epub ahead of print] PubMed PMID: 33846703; PubMed Central PMCID: PMC8026167.
Kuwelker K, Zhou F, Blomberg B, Lartey S, Brokstad KA, Trieu MC, Bansal A, Madsen A, Krammer F, Mohn KG, Tøndel C, Linchausen DW, Cox RJ, Langeland N; Bergen COVID-19 research group. Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. Lancet Reg Health Eur. 2021 Apr;3:100014. doi: 10.1016/j.lanepe.2020.100014. Epub 2021 Mar 31. PubMed PMID: 33871470; PubMed Central PMCID: PMC8009692.

Data Sources

IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

Phones

+34 968885229
+34 968885239
+34 968885249